Log In
Print
BCIQ
Print
Print this Print this
 

CK-2127107

  Manage Alerts
Collapse Summary General Information
Company Cytokinetics Inc.
DescriptionFast skeletal muscle troponin activator
Molecular Target Sarcomere
Mechanism of ActionSarcomere activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular atrophy
Indication DetailsTreat neuromuscular dysfunction, muscular weakness and muscle fatigue; Treat sarcopenia and general frailty
Regulatory Designation

Partner

Astellas Pharma Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$490.0M

0

$112.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today